Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries.

Ross JS, Wang R, Long JB, Gross CP, Ma X.

Arch Intern Med. 2012 Nov 12;172(20):1601-3. doi: 10.1001/archinternmed.2012.3726. No abstract available.

2.

2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.

Prasad SM, Drazer MW, Huo D, Hu JC, Eggener SE.

JAMA. 2012 Apr 25;307(16):1692-4. doi: 10.1001/jama.2012.534. No abstract available.

PMID:
22535850
3.

Grading the new US Preventive Services Task Force prostate cancer screening recommendation.

Volk RJ, Wolf AM.

JAMA. 2011 Dec 28;306(24):2715-6. doi: 10.1001/jama.2011.1893. No abstract available.

PMID:
22203540
4.

The politics of prostate cancer screening.

Kaffenberger SD, Penson DF.

Urol Clin North Am. 2014 May;41(2):249-55. doi: 10.1016/j.ucl.2014.01.004. Epub 2014 Feb 19.

5.

Testing and referral patterns in the years surrounding the US Preventive Services Task Force recommendation against prostate-specific antigen screening.

Hutchinson R, Akhtar A, Haridas J, Bhat D, Roehrborn C, Lotan Y.

Cancer. 2016 Dec 15;122(24):3785-3793. doi: 10.1002/cncr.30330. Epub 2016 Sep 22.

6.

Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations.

Sammon JD, Abdollah F, Choueiri TK, Kantoff PW, Nguyen PL, Menon M, Trinh QD.

JAMA. 2015 Nov 17;314(19):2077-9. doi: 10.1001/jama.2015.7273. No abstract available.

PMID:
26575066
7.

The impact of recent screening recommendations on prostate cancer screening in a large health care system.

Aslani A, Minnillo BJ, Johnson B, Cherullo EE, Ponsky LE, Abouassaly R.

J Urol. 2014 Jun;191(6):1737-42. doi: 10.1016/j.juro.2013.12.010. Epub 2013 Dec 14.

PMID:
24342148
8.

Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.

Schröder FH.

N Engl J Med. 2011 Nov 24;365(21):1953-5. doi: 10.1056/NEJMp1112140. Epub 2011 Oct 26. No abstract available.

9.

Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.

Brett AS, Ablin RJ.

N Engl J Med. 2011 Nov 24;365(21):1949-51. doi: 10.1056/NEJMp1112191. Epub 2011 Oct 26. No abstract available.

10.

Prostate Cancer Screening and the Associated Controversy.

Tabayoyong W, Abouassaly R.

Surg Clin North Am. 2015 Oct;95(5):1023-39. doi: 10.1016/j.suc.2015.05.001. Epub 2015 Jun 23. Review.

PMID:
26315521
11.

National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.

Drazer MW, Huo D, Eggener SE.

J Clin Oncol. 2015 Aug 1;33(22):2416-23. doi: 10.1200/JCO.2015.61.6532. Epub 2015 Jun 8.

PMID:
26056181
12.

Evolution and immediate future of US screening guidelines.

Greene KL, Punnen S, Carroll PR.

Urol Clin North Am. 2014 May;41(2):229-35. doi: 10.1016/j.ucl.2014.01.005. Review.

PMID:
24725485
13.

The United States Preventive Services Task Force recommendations for lung cancer screening.

Blackmon SH, Feinglass SR.

Thorac Surg Clin. 2015 May;25(2):199-203. doi: 10.1016/j.thorsurg.2014.12.004. Epub 2015 Feb 10. Review.

PMID:
25901563
14.

Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.

Cohn JA, Wang CE, Lakeman JC, Silverstein JC, Brendler CB, Novakovic KR, McGuire MS, Helfand BT.

Urol Oncol. 2014 Jan;32(1):41.e23-30. doi: 10.1016/j.urolonc.2013.04.013. Epub 2013 Aug 2.

PMID:
23911680
15.

Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part I: Framing the debate.

Barry MJ, Fleming C, Coley CM, Wasson JH, Fahs MC, Oesterling JE.

Urology. 1995 Jul;46(1):2-13. No abstract available.

PMID:
7541583
16.

Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.

Kwiatkowski M, Klotz L, Hugosson J, Recker F.

Eur Urol. 2012 Apr;61(4):851-4. doi: 10.1016/j.eururo.2012.01.023. Epub 2012 Jan 24. No abstract available.

PMID:
22285762
17.

America, We Are Confused: The Updated U.S. Preventive Services Task Force Recommendation on Colorectal Cancer Screening.

Bretthauer M, Kaminski MF, Hassan C, Kalager M, Holme Ø, Hoff G, Løberg M, Regula J, Castells A, Adami HO.

Ann Intern Med. 2017 Jan 17;166(2):139-140. doi: 10.7326/M16-1805. Epub 2016 Nov 8. No abstract available.

PMID:
27820949
18.

Prostate cancer screening practices and diagnoses in patients age 50 and older, Southeastern Michigan, pre/post 2012.

Rezaee ME, Ward CE, Odom BD, Pollock M.

Prev Med. 2016 Jan;82:73-6. doi: 10.1016/j.ypmed.2015.11.017. Epub 2015 Nov 22.

PMID:
26592690
19.

Prostate Cancer Incidence Rates 2 Years After the US Preventive Services Task Force Recommendations Against Screening.

Jemal A, Ma J, Siegel R, Fedewa S, Brawley O, Ward EM.

JAMA Oncol. 2016 Dec 1;2(12):1657-1660. doi: 10.1001/jamaoncol.2016.2667. No abstract available.

PMID:
27541955
20.

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

Carlsson S, Vickers AJ, Roobol M, Eastham J, Scardino P, Lilja H, Hugosson J.

J Clin Oncol. 2012 Jul 20;30(21):2581-4. doi: 10.1200/JCO.2011.40.4327. Epub 2012 Jun 18. No abstract available.

Supplemental Content

Support Center